EUVIMEDEUVIMED entdecken
Crossref

Efficacy and adverse reaction risk factors of immunotherapy in advanced non-small cell lung cancer: a retrospective study

Qianwen Gao, Lin Jin

American Journal of Cancer Research · 2026 · 16 (10) · 4637-4648

DOI: 10.62347/dfep8664 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Qianwen Gao und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gao, Q., & Jin, L. (2026). Efficacy and adverse reaction risk factors of immunotherapy in advanced non-small cell lung cancer: a retrospective study. American Journal of Cancer Research, 16(10), 4637-4648. https://doi.org/10.62347/dfep8664

Vancouver

Gao Q, Jin L. Efficacy and adverse reaction risk factors of immunotherapy in advanced non-small cell lung cancer: a retrospective study. American Journal of Cancer Research. 2026;16(10):4637-4648. doi:10.62347/dfep8664

BibTeX
@article{Gao2026,
  author = {Gao, Qianwen and Jin, Lin},
  title = {Efficacy and adverse reaction risk factors of immunotherapy in advanced non-small cell lung cancer: a retrospective study},
  journal = {American Journal of Cancer Research},
  year = {2026},
  volume = {16},
  number = {10},
  pages = {4637--4648},
  doi = {10.62347/dfep8664}
}
Kostenlos starten →